Roquefort Therapeutics plc
ROQ.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£1,215 | -£1,745 | -£1,634 | -£917 |
| Dep. & Amort. | £5 | £4 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £21 | £10 | £8 | £275 |
| Change in WC | £9 | -£28 | £39 | -£1,992 |
| Other Non-Cash | £395 | £25 | £9 | £11 |
| Operating Cash Flow | -£784 | -£1,734 | -£1,577 | -£2,623 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | -£54 | £0 | £0 |
| Net Acquisitions | £0 | £0 | -£103 | -£1,106 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £1 | £0 | £0 |
| Investing Cash Flow | £0 | -£53 | -£103 | -£1,106 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £585 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £3,121 | £4,630 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | -£0 | -£19 | £0 |
| Financing Cash Flow | £585 | -£0 | £3,102 | £4,630 |
| Forex Effect | -£1 | £1 | £2 | -£0 |
| Net Chg. in Cash | -£200 | -£1,786 | £1,423 | £900 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £537 | £2,323 | £900 | -£0 |
| End Cash | £337 | £537 | £2,323 | £900 |
| Free Cash Flow | -£784 | -£1,788 | -£1,577 | -£2,623 |